BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A. Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy. JCO 2005;23:1491-9. [DOI: 10.1200/jco.2005.05.187] [Cited by in Crossref: 301] [Cited by in F6Publishing: 318] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 Mestnik S, Wilson S, Huang A, Sato M. Prolonged remission achieved with maintenance intraventricular chemotherapy in young patient with recurrent atypical teratoid rhabdoid tumor. Pediatr Blood Cancer 2023;:e30225. [PMID: 36789544 DOI: 10.1002/pbc.30225] [Reference Citation Analysis]
2 Silva AHD, Habermann S, Craven CL, Bhagawati D, O'Hare P, Jorgensen M, Dahl C, Mankad K, Thompson DNP, Hargrave D, Jeelani NUO, Aquilina K. Atypical teratoid rhabdoid tumours (ATRTs)-a 21-year institutional experience. Childs Nerv Syst 2023. [PMID: 36790496 DOI: 10.1007/s00381-023-05828-0] [Reference Citation Analysis]
3 Smirnova АY, Radulesku GG, Vorobyov NА, Bezyazychnaya IV, Martynova NI, Morgacheva DA, Belogurova MB, Dinikina YV. Proton beam therapy in pediatric patients with central nervous system tumors: method features, clinical data analysis. Ross ž det gematol onkol 2023;9:11-26. [DOI: 10.21682/2311-1267-2022-9-4-11-26] [Reference Citation Analysis]
4 Calandrelli R, Massimi L, Pilato F, Verdolotti T, Ruggiero A, Attinà G, Gessi M, Colosimo C. Atypical Teratoid Rhabdoid Tumor: Proposal of a Diagnostic Pathway Based on Clinical Features and Neuroimaging Findings. Diagnostics (Basel) 2023;13. [PMID: 36766580 DOI: 10.3390/diagnostics13030475] [Reference Citation Analysis]
5 Felton K, Hogg A, Liang L, Aiken C, Klonish T, van Landeghem F, Werbowetski-ogilvie TE, Eisenstat DD. Primary Pediatric Brain Tumors of the Posterior Fossa: Part I. Contemporary Clinical Neuroscience 2023. [DOI: 10.1007/978-3-031-23104-9_18] [Reference Citation Analysis]
6 Han Y, Dong Y, Lian K, Zhang D. Multidisciplinary management of pediatric malignant rhabdoid tumor based on 5 years of experience at a tertiary care center. Pediatr Surg Int 2022;39:51. [PMID: 36522484 DOI: 10.1007/s00383-022-05338-1] [Reference Citation Analysis]
7 Kang X, Xia H, Skudder-Hill L, Yin Y, Wang X. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/Computed Tomography Features of Atypical Teratoid/Rhabdoid Tumors: Case Series and Review. J Child Neurol 2022;37:1003-9. [PMID: 36417494 DOI: 10.1177/08830738221129968] [Reference Citation Analysis]
8 Walker DA. Childhood brain tumors: It is the child’s brain that really matters. Front Oncol 2022;12:982914. [DOI: 10.3389/fonc.2022.982914] [Reference Citation Analysis]
9 Zarei E, Anvari K, Arastouei S, Jafarian AH. Atypical Teratoid/Rhabdoid Tumor in a Young Adult: A Case Report and Literature Review. Rep Radiother Oncol 2022;8. [DOI: 10.5812/rro-129043] [Reference Citation Analysis]
10 Major K, Daggubati LC, Mau C, Zacharia B, Glantz M, Pu C. Sellar Atypical Teratoid/Rhabdoid Tumors (AT/RT): A Systematic Review and Case Illustration. Cureus 2022. [DOI: 10.7759/cureus.26838] [Reference Citation Analysis]
11 Rechberger JS, Nesvick CL, Daniels DJ. Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets. Expert Opin Ther Targets 2022;:1-6. [PMID: 35142587 DOI: 10.1080/14728222.2022.2040017] [Reference Citation Analysis]
12 Uemura S, Demizu Y, Hasegawa D, Fujikawa T, Inoue S, Nishimura A, Tojyo R, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Koyama J, Kawamura A, Akasaka Y, Yoshida M, Fukumitsu N, Soejima T, Kosaka Y. The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors. Cancer Med 2022. [PMID: 35137555 DOI: 10.1002/cam4.4553] [Reference Citation Analysis]
13 Parenrengi MA, Permana GI, Suryaningtyas W, Fauziah D. The aggressive progression of primary intracranial atypical teratoid/rhabdoid tumor after surgical resection: A case report. International Journal of Surgery Case Reports 2022;91:106790. [DOI: 10.1016/j.ijscr.2022.106790] [Reference Citation Analysis]
14 Liu Y, Tsai M, Chen C, Yar N, Tsai C, Lee H, Kuo C, Ho W, Hsieh KL, Tseng S, Miser JS, Chang C, Chang H, Huang W, Wong T, Wu ATH, Yen Y. Atypical Teratoid/Rhabdoid Tumor in Taiwan: A Nationwide, Population-Based Study. Cancers 2022;14:668. [DOI: 10.3390/cancers14030668] [Reference Citation Analysis]
15 Lim JX, Qiu L, Low SYY, Seow WT. Paediatric Brain Tumours: Rare Variants. Pediatric Neurosurgery for Clinicians 2022. [DOI: 10.1007/978-3-030-80522-7_24] [Reference Citation Analysis]
16 Hannon Barroeta P, Magnano S, O'sullivan MJ, Zisterer DM. Evaluation of targeting autophagy for the treatment of malignant rhabdoid tumours. Cancer Treatment and Research Communications 2022;32:100584. [DOI: 10.1016/j.ctarc.2022.100584] [Reference Citation Analysis]
17 Prabhu SP, Poussaint TY. Paediatric brain tumours. Handbook of Neuro-Oncology Neuroimaging 2022. [DOI: 10.1016/b978-0-12-822835-7.00056-1] [Reference Citation Analysis]
18 Elghetany MT, Ho JM, Shi-Qi LH, Karthik S, Su JMF, Lin Q, Du Y, Shen J, Chow WY, Lau CC, Adesina A, Major A, Erdreich-Epstein A, Hui KM, Li XN, Teo WY. Maximizing the potential of aggressive mouse tumor models in preclinical drug testing. Sci Rep 2021;11:11580. [PMID: 34079014 DOI: 10.1038/s41598-021-91167-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Olkhova LV, Zheludkova OG, Zubarovskaya LS, Smirnova AY, Dinikina YV, Kushel YV, Melikyan AG, Gorelyshev SK, Ryzhova MV, Trunin YY, Shults EI, Gevorgyan AG, Gorbatykh SV, Kislyakov AN, Popov VE, Privalova LP, Yudina NB, Tarasova EM, Pogorelov DN, Polushkina OB, Levashov AS, Vorobyov NA, Plakhotina NA, Martynova NI, Skvortsova TY, Zaychikov AN, Mushinskaya MV, Sakun DL, Minkina LM, Lukina TV, Shchepkina EV, Korshunov AG. The results of multicenter treatment of atypical teratoid/rhabdoid tumors of the central nervous system in children under 3 years. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2021;20:121-132. [DOI: 10.24287/1726-1708-2021-20-2-121-132] [Reference Citation Analysis]
20 Hartsell WF, Harris AA, Mihalcik SA, Pankuch M, Gondi V. Advances in Pediatric Radiation Oncology. Advances in Oncology 2021;1:155-167. [DOI: 10.1016/j.yao.2021.02.013] [Reference Citation Analysis]
21 Hoffman LM, Richardson EA, Ho B, Margol A, Reddy A, Lafay-Cousin L, Chi S, Slavc I, Judkins A, Hasselblatt M, Bourdeaut F, Frühwald MC, Vibhakar R, Bouffet E, Huang A. Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors. Neuro Oncol 2020;22:944-54. [PMID: 32129445 DOI: 10.1093/neuonc/noaa046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
22 Jazmati D, Steinmeier T, Ahamd Khalil D, Frisch S, Peters S, Schulze Schleithoff S, Bäumer C, Rutkowski S, Frühwald MC, Blase C, Tippelt S, Timmermann B. Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study. Clin Oncol (R Coll Radiol) 2021;33:e295-304. [PMID: 33820696 DOI: 10.1016/j.clon.2021.03.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Johann P, Wu G, Billups CA, Tatevossian RG, Dhanda SK, Srinivasan A, Broniscer A, Qaddoumi I, Vinitsky A, Armstrong GT, Bendel AE, Hassall T, Partap S, Fisher PG, Crawford JR, Chintagumpala M, Bouffet E, Gururangan S, Mostafavi R, Sanders RP, Klimo P Jr, Patay Z, Indelicato DJ, Nichols KE, Boop FA, Merchant TE, Kool M, Ellison DW, Gajjar A. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials. Clin Cancer Res 2021;27:2879-89. [PMID: 33737307 DOI: 10.1158/1078-0432.CCR-20-4731] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
24 Del Baldo G, Carta R, Alessi I, Merli P, Agolini E, Rinelli M, Boccuto L, Milano GM, Serra A, Carai A, Locatelli F, Mastronuzzi A. Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management. Front Oncol 2021;11:586288. [PMID: 33692948 DOI: 10.3389/fonc.2021.586288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
25 Iqbal L, Nawrocki PS, Radivoj C. Atypical teratoid rhabdoid tumor in the cerebellum of a 7-year-old boy presenting with headache after a fall. J Am Coll Emerg Physicians Open 2021;2:e12353. [PMID: 33491001 DOI: 10.1002/emp2.12353] [Reference Citation Analysis]
26 Liu F, Fan S, Tang X, Fan S, Zhou L. Adult Sellar Region Atypical Teratoid/Rhabdoid Tumor: A Retrospective Study and Literature Review. Front Neurol 2020;11:604612. [PMID: 33384656 DOI: 10.3389/fneur.2020.604612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 Biegel JA, Roth JJ. Rhabdoid Tumors. The Hereditary Basis of Childhood Cancer 2021. [DOI: 10.1007/978-3-030-74448-9_3] [Reference Citation Analysis]
28 Das A, Tabori U. Pediatric Central Nervous System Cancer Predisposition. The Hereditary Basis of Childhood Cancer 2021. [DOI: 10.1007/978-3-030-74448-9_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Cai W, Liu X, Ge W, Wu D, Xu J, Bai R, Hu H. Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study. Int J Med Sci 2021;18:911-20. [PMID: 33456348 DOI: 10.7150/ijms.51186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bennett J, Erker C, Lafay-Cousin L, Ramaswamy V, Hukin J, Vanan MI, Cheng S, Coltin H, Fonseca A, Johnston D, Lo A, Zelcer S, Alvi S, Bowes L, Brossard J, Charlebois J, Eisenstat D, Felton K, Fleming A, Jabado N, Larouche V, Legault G, Mpofu C, Perreault S, Silva M, Sinha R, Strother D, Tsang DS, Wilson B, Crooks B, Bartels U. Canadian Pediatric Neuro-Oncology Standards of Practice. Front Oncol 2020;10:593192. [PMID: 33415075 DOI: 10.3389/fonc.2020.593192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Chasse MH, Johnson BK, Boguslawski EA, Sorensen KM, Rosien JE, Kang MH, Reynolds CP, Heo L, Madaj ZB, Beddows I, Foxa GE, Kitchen-Goosen SM, Williams BO, Triche TJ Jr, Grohar PJ. Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor. EMBO Mol Med 2021;13:e12640. [PMID: 33332735 DOI: 10.15252/emmm.202012640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Park M, Han JW, Hahn SM, Lee JA, Kim JY, Shin SH, Kim DS, Yoon HI, Hong KT, Choi JY, Kang HJ, Shin HY, Phi JH, Kim SK, Lee JW, Yoo KH, Sung KW, Koo HH, Lim DH, Shin HJ, Kim H, Koh KN, Im HJ, Ahn SD, Ra YS, Baek HJ, Kook H, Jung TY, Choi HS, Kim CY, Park HJ, Lyu CJ. Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years. Cancer Res Treat 2021;53:378-88. [PMID: 33138347 DOI: 10.4143/crt.2020.756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Nesvick CL, Lafay-Cousin L, Raghunathan A, Bouffet E, Huang AA, Daniels DJ. Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics. J Neurooncol 2020;150:47-56. [PMID: 33021733 DOI: 10.1007/s11060-020-03639-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
34 Wang X, Wu X, Li T, Cui M, Zhu L, Wang G, Guo F. Identification of Biomarkers to Construct a Competing Endogenous RNA Network and Establishment of a Genomic-Clinicopathologic Nomogram to Predict Survival for Children with Rhabdoid Tumors of the Kidney. Biomed Res Int 2020;2020:5843874. [PMID: 32908900 DOI: 10.1155/2020/5843874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Lőcsei Z, Farkas R, Borbásné Farkas K, Sebestyén K, Sebestyén Z, Musch Z, Vojcek Á, Benedek N, Mangel L, Ottóffy G. Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years. BMC Cancer 2020;20:702. [PMID: 32727407 DOI: 10.1186/s12885-020-07168-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Morin A, Soane C, Pierce A, Sanford B, Jones KL, Crespo M, Zahedi S, Vibhakar R, Mulcahy Levy JM. Proteasome inhibition as a therapeutic approach in atypical teratoid/rhabdoid tumors. Neurooncol Adv 2020;2:vdaa051. [PMID: 32642704 DOI: 10.1093/noajnl/vdaa051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
37 Mousa A, Al-Kofide A, Siddiqui K, Alhindi H, Alshaikh N, Alshail E. Atypical Teratoid Rhabdoid Tumors (ATRT): King Faisal Specialist Hospital and Research Centre experience. Int J Pediatr Adolesc Med 2021;8:154-9. [PMID: 34350327 DOI: 10.1016/j.ijpam.2020.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Berhouma M, Dumot C, Picart T, Vasiljevic A, Ducray F, Faure-conter C, Guyotat J. Tumori della regione pineale. EMC - Neurologia 2020;20:1-15. [DOI: 10.1016/s1634-7072(20)43688-8] [Reference Citation Analysis]
39 Meredith DM. Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System. Adv Anat Pathol 2020;27:206-19. [PMID: 30720470 DOI: 10.1097/PAP.0000000000000225] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Janssens GO, Mandeville HC, Timmermann B, Maduro JH, Alapetite C, Padovani L, Horan G, Lassen-Ramshad Y, Dieckmann K, Ruebe C, Thorp N, Gandola L, Ajithkumar T, Boterberg T. A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises. Radiother Oncol 2020;148:216-22. [PMID: 32342872 DOI: 10.1016/j.radonc.2020.04.035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
41 Yang WC, Yen HJ, Liang ML, Chen HH, Lee YY, Chang FC, Lin SC, Wong TT, Hu YW, Chen YW. Effect of early radiotherapy initiation and high-dose chemotherapy on the prognosis of pediatric atypical teratoid rhabdoid tumors in different age groups. J Neurooncol 2020;147:619-31. [PMID: 32222933 DOI: 10.1007/s11060-020-03456-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Hoffman MM, Zylla JS, Bhattacharya S, Calar K, Hartman TW, Bhardwaj RD, Miskimins WK, de la Puente P, Gnimpieba EZ, Messerli SM. Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid. Cancers (Basel) 2020;12:E756. [PMID: 32210076 DOI: 10.3390/cancers12030756] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
43 Lakhdar F, Benzagmout M, Arkha Y, Chakour K, Chaoui MEF. ATRT of lateral ventricle in a child: A Rare Tumor at a Very Rare Location. Asian J Neurosurg 2020;15:225-9. [PMID: 32181209 DOI: 10.4103/ajns.AJNS_128_19] [Reference Citation Analysis]
44 Smirnova AY, Goncharov AY, Dinikina YV, Kim AV, Khachatryan WA, Belogurova MB. Atypical teratoid-rhabdoid tumors: molecular genetics feutures, perspectives of treatment. Review of literature. Ross ž det gematol onkol 2020;7:41-50. [DOI: 10.21682/2311-1267-2020-7-1-41-50] [Reference Citation Analysis]
45 Reddy AT, Strother DR, Judkins AR, Burger PC, Pollack IF, Krailo MD, Buxton AB, Williams-Hughes C, Fouladi M, Mahajan A, Merchant TE, Ho B, Mazewski CM, Lewis VA, Gajjar A, Vezina LG, Booth TN, Parsons KW, Poss VL, Zhou T, Biegel JA, Huang A. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. J Clin Oncol 2020;38:1175-85. [PMID: 32105509 DOI: 10.1200/JCO.19.01776] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 17.7] [Reference Citation Analysis]
46 Xu C, Wu C, Lou M, Zhao Y. Cure of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: A Case Report. CRCM 2020;09:15-21. [DOI: 10.4236/crcm.2020.91003] [Reference Citation Analysis]
47 Le Loarer F. Rhabdoid Tumor, Soft Tissue. Encyclopedia of Pathology 2020. [DOI: 10.1007/978-3-319-28845-1_5489-1] [Reference Citation Analysis]
48 Sengupta S, Krummel DP, Weinberg BD, Macdonald TJ. High-Grade Tumors of the Brainstem (Except DIPG). Brainstem Tumors 2020. [DOI: 10.1007/978-3-030-38774-7_7] [Reference Citation Analysis]
49 Nicholls L, Kopp LM. Immunotherapy for Pediatric Solid Tumors. Cancer Immunology 2020. [DOI: 10.1007/978-3-030-57949-4_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Choi J, Rui Y, Kim J, Gorelick N, Wilson DR, Kozielski K, Mangraviti A, Sankey E, Brem H, Tyler B, Green JJ, Jackson EM. Nonviral polymeric nanoparticles for gene therapy in pediatric CNS malignancies. Nanomedicine 2020;23:102115. [PMID: 31655205 DOI: 10.1016/j.nano.2019.102115] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
51 Faltermeier C, Chai T, Syed S, Lau N, Elkaim L, Ibrahim G, Wang A, Weil A, Bendel A, Fallah A, Tu A. Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database. PLoS One 2019;14:e0223051. [PMID: 31553771 DOI: 10.1371/journal.pone.0223051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Stroup EK, Yeu Y, Budhipramono A, Hwang TH, Rakheja D, Erdreich‐epstein A, Laetsch TW, Amatruda JF, Chen KS. WT‐CLS1 is a rhabdoid tumor cell line and can be inhibited by miR ‐16. Cancer Reports 2019;2. [DOI: 10.1002/cnr2.1110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
53 Carugo A, Minelli R, Sapio L, Soeung M, Carbone F, Robinson FS, Tepper J, Chen Z, Lovisa S, Svelto M, Amin S, Srinivasan S, Del Poggetto E, Loponte S, Puca F, Dey P, Malouf GG, Su X, Li L, Lopez-Terrada D, Rakheja D, Lazar AJ, Netto GJ, Rao P, Sgambato A, Maitra A, Tripathi DN, Walker CL, Karam JA, Heffernan TP, Viale A, Roberts CWM, Msaouel P, Tannir NM, Draetta GF, Genovese G. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors. Cancer Cell 2019;35:204-220.e9. [PMID: 30753823 DOI: 10.1016/j.ccell.2019.01.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 11.8] [Reference Citation Analysis]
54 Taschner CA, Erny D, Shah MJ, Urbach H, Feige U, Prinz M. Freiburg Neuropathology Case Conference : Posterior Fossa Mass in an Infant. Clin Neuroradiol 2019;29:177-84. [PMID: 30734054 DOI: 10.1007/s00062-019-00759-3] [Reference Citation Analysis]
55 Dinikina YV, Belogurova MB. Atypical teratoid/rhabdoid tumors of the central nervous system in children: the state of the problem today. Literature review. Ross ž det gematol onkol 2019;5:60-73. [DOI: 10.17650/2311-1267-2018-5-4-60-73] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Lindsay H, Huang A. Atypical Teratoid Rhabdoid Tumors. Oncology of CNS Tumors 2019. [DOI: 10.1007/978-3-030-04152-6_33] [Reference Citation Analysis]
57 Kohorst MA, Khan SP. Hematopoietic Cell Transplantation for Pediatric Solid Tumors. Hematopoietic Cell Transplantation for Malignant Conditions 2019. [DOI: 10.1016/b978-0-323-56802-9.00021-3] [Reference Citation Analysis]
58 Jaramillo S, Grosshans DR, Philip N, Varan A, Akyüz C, McAleer MF, Mahajan A, McGovern SL. Radiation for ETMR: Literature review and case series of patients treated with proton therapy. Clin Transl Radiat Oncol 2019;15:31-7. [PMID: 30582019 DOI: 10.1016/j.ctro.2018.11.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
59 Nesvick CL, Nageswara Rao AA, Raghunathan A, Biegel JA, Daniels DJ. Case-based review: atypical teratoid/rhabdoid tumor. Neurooncol Pract 2019;6:163-78. [PMID: 31386032 DOI: 10.1093/nop/npy037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
60 Kram DE, Henderson JJ, Baig M, Chakraborty D, Gardner MA, Biswas S, Khatua S. Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted Therapeutics. Bioengineering (Basel) 2018;5:E78. [PMID: 30249036 DOI: 10.3390/bioengineering5040078] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
61 Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, Garnier E, Gandola L, Meroni S, Hoeben BAW, Kusters M, Alapetite C, Losa S, Goudjil F, Magelssen H, Evensen ME, Saran F, Smyth G, Rombi B, Righetto R, Kortmann RD, Janssens GO. Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group). Acta Oncol 2018;57:1240-9. [PMID: 29698060 DOI: 10.1080/0284186X.2018.1465588] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 7.4] [Reference Citation Analysis]
62 Lee YE, Choi SA, Kwack PA, Kim HJ, Kim IH, Wang KC, Phi JH, Lee JY, Chong S, Park SH, Park KD, Hwang DW, Joo KM, Kim SK. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor. Neuro Oncol 2017;19:1079-87. [PMID: 28340172 DOI: 10.1093/neuonc/now300] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
63 Kehrer-Sawatzki H, Kordes U, Seiffert S, Summerer A, Hagel C, Schüller U, Farschtschi S, Schneppenheim R, Bendszus M, Godel T, Mautner VF. Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1. Mol Genet Genomic Med 2018. [PMID: 29779243 DOI: 10.1002/mgg3.412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
64 Lim DH. Radiation Therapy against Pediatric Malignant Central Nervous System Tumors : Embryonal Tumors and Proton Beam Therapy. J Korean Neurosurg Soc 2018;61:386-92. [PMID: 29742879 DOI: 10.3340/jkns.2018.0004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
65 Richardson EA, Ho B, Huang A. Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies. J Korean Neurosurg Soc 2018;61:302-11. [PMID: 29742888 DOI: 10.3340/jkns.2018.0061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
66 Yoshida K, Fujiwara Y, Goto Y, Kohno T, Yoshida A, Tsuta K, Ohe Y. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report. BMC Cancer 2018;18:398. [PMID: 29625594 DOI: 10.1186/s12885-018-4321-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
67 Ren YM, Wu X, You C, Zhang YK, Li Q, Ju Y. Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients. Childs Nerv Syst 2018;34:627-38. [PMID: 29218405 DOI: 10.1007/s00381-017-3688-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
68 Timmermann B, Kortmann R. Embryonal Tumors. Radiation Oncology 2018. [DOI: 10.1007/978-3-319-52619-5_5-1] [Reference Citation Analysis]
69 Guerreiro Stucklin AS, Grotzer MA. Cerebellar tumors. The Cerebellum: Disorders and Treatment 2018. [DOI: 10.1016/b978-0-444-64189-2.00019-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
70 Mcgovern SL. Atypical Teratoid Rhabdoid Tumors (AT/RT) and ETMR. Radiation Oncology for Pediatric CNS Tumors 2018. [DOI: 10.1007/978-3-319-55430-3_8] [Reference Citation Analysis]
71 Mcfarren A, Pulsipher MA. Pretransplantation: Indications and Timing. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist 2018. [DOI: 10.1007/978-3-319-63146-2_4] [Reference Citation Analysis]
72 Reddy AT, Waite ES. Chemotherapy for CNS Atypical Teratoid/Rhabdoid Tumor. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 2018. [DOI: 10.1016/b978-0-12-812100-9.00049-8] [Reference Citation Analysis]
73 Song H, Kim Y, Lee J, Chang S, Sohn M. Atypical Teratoid/Rhabdoid Tumor of Lumbar Spine in an Infant: A Case Report. J Korean Soc Radiol 2018;78:417. [DOI: 10.3348/jksr.2018.78.6.417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
74 Fonseca A, Al-karmi S, Vasiljevic A, Dodghsun A, Chan PS, Cousin LL, Hansford J, Huang A. Rare Embryonal Brain Tumours. Brain Tumors in Children 2018. [DOI: 10.1007/978-3-319-43205-2_13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
75 Conklin HM, Schreiber JE, Fournier-goodnight AS. Cognitive Late Effects and Their Management. Brain Tumors in Children 2018. [DOI: 10.1007/978-3-319-43205-2_14] [Reference Citation Analysis]
76 Macdonald SM, Bindra RS, Sethi R, Ladra M. Principles of Radiation Oncology. Brain Tumors in Children 2018. [DOI: 10.1007/978-3-319-43205-2_3] [Reference Citation Analysis]
77 Al Duhaiby E, Tinkle C, Aridgides P. Atypical Teratoid/Rhabdoid Tumor (AT/RT). Pediatric Radiation Oncology 2018. [DOI: 10.1007/978-3-319-43545-9_10] [Reference Citation Analysis]
78 Stroup EK, Yeu Y, Budhipramono A, Hwang TH, Rakheja D, Erdreich-epstein A, Laetsch TW, Amatruda JF, Chen KS. miR-16 Suppresses Growth of Rhabdoid Tumor Cells.. [DOI: 10.1101/219709] [Reference Citation Analysis]
79 Dardis C, Yeo J, Milton K, Ashby LS, Smith KA, Mehta S, Youssef E, Eschbacher J, Tucker K, Dawes L, Lambie N, Algar E, Hovey E. Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment. Front Neurol. 2017;8:247. [PMID: 28676785 DOI: 10.3389/fneur.2017.00247] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
80 Gershanov S, Michowiz S, Toledano H, Yahav G, Barinfeld O, Hirshberg A, Ben-Zvi H, Mircus G, Salmon-Divon M, Fixler D, Goldenberg-Cohen N. Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with Medulloblastoma. Sci Rep 2017;7:3648. [PMID: 28623325 DOI: 10.1038/s41598-017-03892-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
81 Shokripour M, Azarpira N, Omidifar N, Pakniat B. Cytologic diagnosis of atypical teratoid rhabdoid tumor based on touch imprint study: Report of a case with review of literature. J Educ Health Promot 2017;6:59. [PMID: 28616426 DOI: 10.4103/jehp.jehp_8_17] [Reference Citation Analysis]
82 Frick M, Minturn JE, Li Y, Hill-kayser C. Radiotherapy-related outcomes in pediatric patients with atypical teratoid thabdoid tumor of the central nervous system. J Radiat Oncol 2017;6:153-160. [DOI: 10.1007/s13566-016-0271-6] [Reference Citation Analysis]
83 Story E, Johnston DL, Bartels U, Carret AS, Crooks B, Eisenstat DD, Fryer C, Lafay-Cousin L, Larouche V, Wilson B, Zelcer S, Silva M, Brossard J, Bouffet E, Keene DL. Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC). J Neurooncol 2017;133:581-7. [PMID: 28508928 DOI: 10.1007/s11060-017-2468-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
84 Macdonald SM, Yock TI, Tarbell NJ, Vern-gross TZ. Pediatric Tumors. Clinical Radiation Oncology 2017. [DOI: 10.1002/9781119341154.ch41] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Chao MF, Su YF, Jaw TS, Chiou SS, Lin CH. Atypical teratoid/rhabdoid tumor of lumbar spine in a toddler child. Spinal Cord Ser Cases 2017;3:16026. [PMID: 28503314 DOI: 10.1038/scsandc.2016.26] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
86 Ud Din N, Barakzai A, Memon A, Hasan Sh, Ahmad Z. Atypical Teratoid/ Rhabdoid Tumor of Brain: a Clinicopathologic Study of Eleven Patients and Review of Literature. Asian Pac J Cancer Prev 2017;18:949-54. [PMID: 28545192 DOI: 10.22034/APJCP.2017.18.4.949] [Reference Citation Analysis]
87 Castellino RC, Schniederjan M, Macdonald TJ. Uncommon Pediatric Brain Tumors. Textbook of Uncommon Cancer 2017. [DOI: 10.1002/9781119196235.ch79] [Reference Citation Analysis]
88 Kenney AM, Castellino RC, Moots PL, Corso CD, Mehta MP. Medulloblastoma in Adults. Textbook of Uncommon Cancer 2017. [DOI: 10.1002/9781119196235.ch65] [Reference Citation Analysis]
89 Raleigh D, Raffel C, Haas-kogan DA. Embryonal Tumors. Pediatric Oncology 2017. [DOI: 10.1007/978-3-319-30789-3_5] [Reference Citation Analysis]
90 Felton K, Hogg A, Liang L, Aiken C, Klonisch T, van Landeghem F, Werbowetski-ogilvie TE, Eisenstat DD. Primary Pediatric Brain Tumors of the Posterior Fossa: Part I. Contemporary Clinical Neuroscience 2017. [DOI: 10.1007/978-3-319-59749-2_15] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
91 Reddy AT, Chi SN, Biegel JA. Atypical Teratoid/Rhabdoid Tumors. Swaiman's Pediatric Neurology 2017. [DOI: 10.1016/b978-0-323-37101-8.00129-6] [Reference Citation Analysis]
92 Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, Planello AC, Zeller C, Barsyte-Lovejoy D, Lafay-Cousin L, Letourneau L, Bourgey M, Yu M, Gendoo DMA, Dzamba M, Barszczyk M, Medina T, Riemenschneider AN, Morrissy AS, Ra YS, Ramaswamy V, Remke M, Dunham CP, Yip S, Ng HK, Lu JQ, Mehta V, Albrecht S, Pimentel J, Chan JA, Somers GR, Faria CC, Roque L, Fouladi M, Hoffman LM, Moore AS, Wang Y, Choi SA, Hansford JR, Catchpoole D, Birks DK, Foreman NK, Strother D, Klekner A, Bognár L, Garami M, Hauser P, Hortobágyi T, Wilson B, Hukin J, Carret AS, Van Meter TE, Hwang EI, Gajjar A, Chiou SH, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheinemann K, Fleming AJ, Johnston DL, Michaud J, Zelcer S, Hammond R, Afzal S, Ramsay DA, Sirachainan N, Hongeng S, Larbcharoensub N, Grundy RG, Lulla RR, Fangusaro JR, Druker H, Bartels U, Grant R, Malkin D, McGlade CJ, Nicolaides T, Tihan T, Phillips J, Majewski J, Montpetit A, Bourque G, Bader GD, Reddy AT, Gillespie GY, Warmuth-Metz M, Rutkowski S, Tabori U, Lupien M, Brudno M, Schüller U, Pietsch T, Judkins AR, Hawkins CE, Bouffet E, Kim SK, Dirks PB, Taylor MD, Erdreich-Epstein A, Arrowsmith CH, De Carvalho DD, Rutka JT, Jabado N, Huang A. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell 2016;30:891-908. [PMID: 27960086 DOI: 10.1016/j.ccell.2016.11.003] [Cited by in Crossref: 159] [Cited by in F6Publishing: 129] [Article Influence: 22.7] [Reference Citation Analysis]
93 Kramer K. Rare Primary Central Nervous System Tumors Encountered in Pediatrics. J Child Neurol 2016;31:1394-8. [PMID: 26801774 DOI: 10.1177/0883073815627878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Biswas A, Kashyap L, Kakkar A, Sarkar C, Julka PK. Atypical teratoid/rhabdoid tumors: challenges and search for solutions. Cancer Manag Res. 2016;8:115-125. [PMID: 27695363 DOI: 10.2147/cmar.s83472] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
95 Geller JI, Roth JJ, Biegel JA. Biology and Treatment of Rhabdoid Tumor. Crit Rev Oncog 2015;20:199-216. [PMID: 26349416 DOI: 10.1615/critrevoncog.2015013566] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 9.6] [Reference Citation Analysis]
96 Elsayad K, Kriz J, Samhouri L, Haverkamp U, Straeter R, Stummer W, Eich HT. Long-term survival following additive radiotherapy in patients with atypical teratoid rhabdoid tumors. Strahlenther Onkol 2016;192:569-81. [PMID: 27272756 DOI: 10.1007/s00066-016-0978-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
97 Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Dürken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Schmid I, Schneppenheim R, Siebert R, Solano-Paez P, Timmermann B, Warmuth-Metz M, Frühwald MC. Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007. Cancer Med 2016;5:1765-75. [PMID: 27228363 DOI: 10.1002/cam4.741] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
98 Nodomi S, Umeda K, Saida S, Kinehara T, Hamabata T, Daifu T, Kato I, Hiramatsu H, Watanabe KI, Kuwahara Y, Iehara T, Adachi S, Konishi E, Nakahata T, Hosoi H, Heike T. CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor. Oncogene 2016;35:5317-27. [PMID: 27041577 DOI: 10.1038/onc.2016.72] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
99 Sung KW, Lim DH, Yi ES, Choi YB, Lee JW, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor. Cancer Res Treat 2016;48:1408-19. [PMID: 27034140 DOI: 10.4143/crt.2015.347] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
100 Chun HE, Lim EL, Heravi-Moussavi A, Saberi S, Mungall KL, Bilenky M, Carles A, Tse K, Shlafman I, Zhu K, Qian JQ, Palmquist DL, He A, Long W, Goya R, Ng M, LeBlanc VG, Pleasance E, Thiessen N, Wong T, Chuah E, Zhao YJ, Schein JE, Gerhard DS, Taylor MD, Mungall AJ, Moore RA, Ma Y, Jones SJM, Perlman EJ, Hirst M, Marra MA. Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways. Cancer Cell 2016;29:394-406. [PMID: 26977886 DOI: 10.1016/j.ccell.2016.02.009] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 13.3] [Reference Citation Analysis]
101 Frühwald MC, Biegel JA, Bourdeaut F, Roberts CW, Chi SN. Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies. Neuro Oncol 2016;18:764-78. [PMID: 26755072 DOI: 10.1093/neuonc/nov264] [Cited by in Crossref: 151] [Cited by in F6Publishing: 157] [Article Influence: 21.6] [Reference Citation Analysis]
102 Johansson G, Andersson U, Melin B. Recent developments in brain tumor predisposing syndromes. Acta Oncol 2016;55:401-11. [PMID: 26634384 DOI: 10.3109/0284186X.2015.1107190] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
103 Cox MC, Kusters JM, Gidding CE, Schieving JH, van Lindert EJ, Kaanders JH, Janssens GO. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis. Radiat Oncol 2015;10:241. [PMID: 26597178 DOI: 10.1186/s13014-015-0547-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
104 DiPatri AJ Jr, Sredni ST, Grahovac G, Tomita T. Atypical teratoid rhabdoid tumors of the posterior fossa in children. Childs Nerv Syst 2015;31:1717-28. [PMID: 26351225 DOI: 10.1007/s00381-015-2844-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
105 Lau CS, Mahendraraj K, Chamberlain RS. Atypical teratoid rhabdoid tumors: a population-based clinical outcomes study involving 174 patients from the Surveillance, Epidemiology, and End Results database (1973-2010). Cancer Manag Res 2015;7:301-9. [PMID: 26425106 DOI: 10.2147/CMAR.S88561] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
106 Hanafy E. Sacrococcygeal Atypical Teratoid/ Rhabdoid Tumor in an Infant. JCPCR 2015;3. [DOI: 10.15406/jcpcr.2015.03.00070] [Reference Citation Analysis]
107 Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape. J Clin Oncol 2015;33:2986-98. [PMID: 26304884 DOI: 10.1200/JCO.2014.59.9217] [Cited by in Crossref: 142] [Cited by in F6Publishing: 149] [Article Influence: 17.8] [Reference Citation Analysis]
108 Verma V, Johnson CP, Bennion NR, Bhirud AR, Li S, McComb RD, Lin C. Atypical teratoid rhabdoid tumor: long-term survival after chemoradiotherapy. Childs Nerv Syst 2015;31:1393-9. [PMID: 25939716 DOI: 10.1007/s00381-015-2723-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
109 Ho DM, Shih CC, Liang ML, Tsai CY, Hsieh TH, Tsai CH, Lin SC, Chang TY, Chao ME, Wang HW, Wong TT. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors. BMC Med Genomics 2015;8:32. [PMID: 26109171 DOI: 10.1186/s12920-015-0103-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
110 Taillibert S, Le Rhun E, Chamberlain MC. Intracranial cystic lesions: a review. Curr Neurol Neurosci Rep 2014;14:481. [PMID: 25106500 DOI: 10.1007/s11910-014-0481-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
111 Wetmore C, Boyett J, Li S, Lin T, Bendel A, Gajjar A, Orr BA. Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children. Neuro Oncol 2015;17:882-8. [PMID: 25688119 DOI: 10.1093/neuonc/nov017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 6.3] [Reference Citation Analysis]
112 DeWire M, Green DM, Sklar CA, Merchant TE, Wallace D, Lin T, Vern-Gross T, Kun LE, Krasin MJ, Boyett JM, Wright KD, Wetmore C, Broniscer A, Gajjar A. Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy. Pediatr Blood Cancer 2015;62:329-34. [PMID: 25327609 DOI: 10.1002/pbc.25274] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
113 Tabori U, Karajannis MA, Pappas JG. Hereditary Predisposition to Primary CNS Tumors. Molecular Pathology Library 2015. [DOI: 10.1007/978-1-4939-1830-0_1] [Reference Citation Analysis]
114 Di Rocco C, Massimi L. Atypical Teratoid/Rhabdoid Tumor: Surgery. Posterior Fossa Tumors in Children 2015. [DOI: 10.1007/978-3-319-11274-9_40] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Canpolat C. Atypical Teratoid/Rhabdoid Tumors: Current Chemotherapy and Future Directions. Posterior Fossa Tumors in Children 2015. [DOI: 10.1007/978-3-319-11274-9_42] [Reference Citation Analysis]
116 Wang X, Liu X, Lin Z, Chen Y, Wang P, Zhang S. Atypical teratoid/rhabdoid tumor (AT/RT) arising from the acoustic nerve in a young adult: a case report and a review of literature. Medicine (Baltimore) 2015;94:e439. [PMID: 25634176 DOI: 10.1097/MD.0000000000000439] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
117 Caglar HB. Radiation Therapy in Atypical Teratoid/Rhabdoid Tumors. Posterior Fossa Tumors in Children 2015. [DOI: 10.1007/978-3-319-11274-9_43] [Reference Citation Analysis]
118 Tabori U, Laberge A, Ellezam B, Carret A. Cancer Predisposition in Children with Brain Tumors. Pediatric Neuro-oncology 2015. [DOI: 10.1007/978-1-4939-1541-5_8] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
119 Richard HT, Harrison JF, Fuller C. Central Nervous System Tumors. Molecular Oncology Testing for Solid Tumors 2015. [DOI: 10.1007/978-3-319-16304-8_16] [Reference Citation Analysis]
120 Charles AK. Congenital Tumors. Keeling’s Fetal and Neonatal Pathology 2015. [DOI: 10.1007/978-3-319-19207-9_18] [Reference Citation Analysis]
121 Shalaby T, Fiaschetti G, Baumgartner M, Grotzer MA. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons. Int J Mol Sci 2014;15:21554-86. [PMID: 25421247 DOI: 10.3390/ijms151121554] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
122 Sinha P, Ahmad M, Varghese A, Parekh T, Ismail A, Chakrabarty A, Tyagi A, Chumas P. Atypical teratoid rhabdoid tumour of the spine: report of a case and literature review. Eur Spine J 2015;24 Suppl 4:S472-84. [PMID: 25374299 DOI: 10.1007/s00586-014-3445-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
123 Choi SA, Choi JW, Wang KC, Phi JH, Lee JY, Park KD, Eum D, Park SH, Kim IH, Kim SK. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors. Neuro Oncol 2015;17:810-21. [PMID: 25378634 DOI: 10.1093/neuonc/nou305] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
124 McGovern SL, Okcu MF, Munsell MF, Kumbalasseriyil N, Grosshans DR, McAleer MF, Chintagumpala M, Khatua S, Mahajan A. Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. Int J Radiat Oncol Biol Phys 2014;90:1143-52. [PMID: 25311260 DOI: 10.1016/j.ijrobp.2014.08.354] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 7.9] [Reference Citation Analysis]
125 Odagiri K, Omura M, Hata M, Aida N, Niwa T, Goto H, Ito S, Adachi M, Yoshida H, Yuki H, Inoue T. Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors. Radiat Oncol 2014;9:201. [PMID: 25209395 DOI: 10.1186/1748-717X-9-201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
126 Kubicky CD, Sahgal A, Chang EL, Lo SS. Rare primary central nervous system tumors. Rare Tumors 2014;6:5449. [PMID: 25276324 DOI: 10.4081/rt.2014.5449] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
127 Shitara S, Akiyama Y. Atypical teratoid/rhabdoid tumor in sellar turcica in an adult: A case report and review of the literature. Surg Neurol Int 2014;5:75. [PMID: 24949218 DOI: 10.4103/2152-7806.133105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
128 Ostrom QT, Chen Y, M de Blank P, Ondracek A, Farah P, Gittleman H, Wolinsky Y, Kruchko C, Cohen ML, Brat DJ, Barnholtz-Sloan JS. The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010. Neuro Oncol 2014;16:1392-9. [PMID: 24847086 DOI: 10.1093/neuonc/nou090] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 7.8] [Reference Citation Analysis]
129 Warren KS, Oxley J, Koupparis A. Pure malignant rhabdoid tumour of the bladder. Can Urol Assoc J 2014;8:E260-2. [PMID: 24839495 DOI: 10.5489/cuaj.1633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
130 Shalaby T, Fiaschetti G, Baumgartner M, Grotzer MA. Significance and therapeutic value of miRNAs in embryonal neural tumors. Molecules 2014;19:5821-62. [PMID: 24806581 DOI: 10.3390/molecules19055821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
131 Benesch M, Bartelheim K, Fleischhack G, Gruhn B, Schlegel PG, Witt O, Stachel KD, Hauch H, Urban C, Quehenberger F, Massimino M, Pietsch T, Hasselblatt M, Giangaspero F, Kordes U, Schneppenheim R, Hauser P, Klingebiel T, Frühwald MC. High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB). Bone Marrow Transplant 2014;49:370-5. [PMID: 24419520 DOI: 10.1038/bmt.2013.208] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
132 Inoue N, Watanabe H, Okamura K, Sakaki M, Kageji T, Nagahiro S, Kagami S. Atypical teratoid rhabdoid tumor in the cavernous sinus of a toddler presenting with oculomotor nerve palsy. Childs Nerv Syst 2014;30:1463-6. [PMID: 24682530 DOI: 10.1007/s00381-014-2407-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
133 Slavc I, Chocholous M, Leiss U, Haberler C, Peyrl A, Azizi AA, Dieckmann K, Woehrer A, Peters C, Widhalm G, Dorfer C, Czech T. Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012. Cancer Med 2014;3:91-100. [PMID: 24402832 DOI: 10.1002/cam4.161] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
134 Shim KW, Xi G, Farnell BM, Kim DS, Tsurubuchi T, Tomita T, Mayanil CS. Epigenetic modification after inhibition of IGF-1R signaling in human central nervous system atypical teratoid rhabdoid tumor (AT/RT). Childs Nerv Syst 2013;29:1245-51. [PMID: 23624780 DOI: 10.1007/s00381-013-2087-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
135 Modena P, Sardi I, Brenca M, Giunti L, Buccoliero AM, Pollo B, Biassoni V, Genitori L, Antonelli M, Maestro R, Giangaspero F, Massimino M. Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor. BMC Cancer 2013;13:100. [PMID: 23510391 DOI: 10.1186/1471-2407-13-100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
136 Kai M. DNA Repair Mechanisms in Other Cancer Stem Cell Models. DNA Repair of Cancer Stem Cells 2013. [DOI: 10.1007/978-94-007-4590-2_7] [Reference Citation Analysis]
137 Takei H, Langford LA. Atypical Teratoid/Rhabdoid Tumor of the Pineal Region: Diagnosis. Pediatric Cancer, Volume 4 2013. [DOI: 10.1007/978-94-007-6591-7_20] [Reference Citation Analysis]
138 Imagama S, Wakao N, Ando K, Hirano K, Tauchi R, Muramoto A, Matsui H, Matsumoto T, Ukai J, Kobayashi K, Shinjo R, Nakashima H, Maruyama K, Matsuyama Y, Ishiguro N. Treatment for primary spinal atypical teratoid/rhabdoid tumor. J Orthop Sci 2012;17:822-7. [PMID: 21720800 DOI: 10.1007/s00776-011-0122-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
139 Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright KD, Qaddoumi I, Armstrong GT, Broniscer A, Gajjar A. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys 2012;83:e655-60. [PMID: 22768993 DOI: 10.1016/j.ijrobp.2012.01.061] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
140 Ginn KF, Gajjar A. Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol. 2012;2:114. [PMID: 22988546 DOI: 10.3389/fonc.2012.00114] [Cited by in Crossref: 108] [Cited by in F6Publishing: 121] [Article Influence: 9.8] [Reference Citation Analysis]
141 Campen CJ, Dearlove J, Partap S, Murphy P, Gibbs IC, Dahl GV, Fisher PG. Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors. J Neurooncol 2012;110:287-91. [PMID: 22941430 DOI: 10.1007/s11060-012-0969-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
142 Villani A, Malkin D, Tabori U. Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises. Curr Neurol Neurosci Rep 2012;12:153-64. [PMID: 22205236 DOI: 10.1007/s11910-011-0244-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
143 Subbiah V, Wolff J, Ketonen L, Ellezam B, Rytting ME. Advanced atypical teratoid/rhabdoid tumor (ATRT) treated with intensive multimodal approach shows continued response to sarcoma type salvage therapy. Pediatr Blood Cancer 2012;58:823-4. [PMID: 21922648 DOI: 10.1002/pbc.23322] [Reference Citation Analysis]
144 Castellino RC, Schniederjan M, Macdonald TJ. Uncommon Pediatric Brain Tumors. Textbook of Uncommon Cancer 2012. [DOI: 10.1002/9781118464557.ch69] [Reference Citation Analysis]
145 Moots PL, Kenney AM. Medulloblastoma in Adults. Textbook of Uncommon Cancer 2012. [DOI: 10.1002/9781118464557.ch59] [Reference Citation Analysis]
146 Fleming AJ, Hukin J, Rassekh R, Fryer C, Kim J, Stemmer-Rachamimov A, Birks DK, Huang A, Yip S, Dunham C. Atypical teratoid rhabdoid tumors (ATRTs): the British Columbia's Children's Hospital's experience, 1986-2006. Brain Pathol 2012;22:625-35. [PMID: 22188464 DOI: 10.1111/j.1750-3639.2011.00561.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
147 Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC, Lim DH, Kim HS. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system. J Korean Med Sci 2012;27:135-40. [PMID: 22323859 DOI: 10.3346/jkms.2012.27.2.135] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
148 Weeks A, Fallah A, Rutka JT. Posterior Fossa and Brainstem Tumors in Children. Principles of Neurological Surgery 2012. [DOI: 10.1016/b978-1-4377-0701-4.00010-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
149 Stabouli S. Pediatric Atypical Teratoid/Rhabdoid Tumor in the Spine: Diagnosis and Treatment. Pediatric Cancer, Volume 3 2012. [DOI: 10.1007/978-94-007-4528-5_6] [Reference Citation Analysis]
150 Haberler C, Slavc I. Early Childhood Atypical Teratoid/Rhabdoid Tumors. Pediatric Cancer, Volume 3 2012. [DOI: 10.1007/978-94-007-4528-5_1] [Reference Citation Analysis]
151 Sredni ST, Lulla RR. Atypical Teratoid/Rhabdoid Tumors. Pediatric Cancer, Volume 3 2012. [DOI: 10.1007/978-94-007-4528-5_2] [Reference Citation Analysis]
152 Warmuth-metz M, Frühwald M. Pediatric Atypical Teratoid/Rhabdoid Tumors: Imaging with CT and MRI. Pediatric Cancer 2012. [DOI: 10.1007/978-94-007-2957-5_4] [Reference Citation Analysis]
153 Lee J, Chung N. The role of chemotherapy in the treatment of pediatric brain tumors. J Korean Med Assoc 2012;55:420. [DOI: 10.5124/jkma.2012.55.5.420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
154 Koral K, Bowers DC. Pediatric Atypical Teratoid/Rhabdoid Tumor. Pediatric Cancer 2012. [DOI: 10.1007/978-94-007-2957-5_2] [Reference Citation Analysis]
155 Kramarz MJ, Jackson EM, Resnick AC, Storm PB. Early Childhood Clival-C2 Atypical Teratoid/Rhabdoid Tumor: Gross Total Resection Followed by Aggressive Chemotherapy and Radiation. Pediatric Cancer, Volume 3 2012. [DOI: 10.1007/978-94-007-4528-5_7] [Reference Citation Analysis]
156 Arslanoglu A. Atypical Teratoid/Rhabdoid Tumors: Diagnosis Using Imaging. Pediatric Cancer, Volume 3 2012. [DOI: 10.1007/978-94-007-4528-5_5] [Reference Citation Analysis]
157 Pollack IF. Pediatric Brain Tumors: Application of Stratification Criteria to Refine Patient Management. Pediatric Cancer 2012. [DOI: 10.1007/978-94-007-2957-5_21] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Bansal KK, Goel D. Pediatric Atypical Teratoid/Rhabdoid Tumors (An Overview). Pediatric Cancer 2012. [DOI: 10.1007/978-94-007-2957-5_1] [Reference Citation Analysis]
159 Packer RJ, Macdonald TJ, Vezina G. Tumors of the Brain and Spine. Swaiman's Pediatric Neurology 2012. [DOI: 10.1016/b978-1-4377-0435-8.00102-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
160 Lim DH. Radiation therapy for pediatric brain tumors. J Korean Med Assoc 2012;55:447. [DOI: 10.5124/jkma.2012.55.5.447] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Jayanthan A, Bernoux D, Bose P, Riabowol K, Narendran A. Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition. Cancer Cell Int 2011;11:44. [PMID: 22206574 DOI: 10.1186/1475-2867-11-44] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
162 Knipstein JA, Birks DK, Donson AM, Alimova I, Foreman NK, Vibhakar R. Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells. Neuro Oncol. 2012;14:175-183. [PMID: 22156471 DOI: 10.1093/neuonc/nor208] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
163 Lee JY, Kim IK, Phi JH, Wang KC, Cho BK, Park SH, Ahn HS, Kim IH, Kim SK. Atypical teratoid/rhabdoid tumors: the need for more active therapeutic measures in younger patients. J Neurooncol 2012;107:413-9. [PMID: 22134767 DOI: 10.1007/s11060-011-0769-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
164 Shonka NA, Armstrong TS, Prabhu SS, Childress A, Choi S, Langford LA, Gilbert MR. Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review. J Clin Med Res 2011;3:85-92. [PMID: 21811535 DOI: 10.4021/jocmr535w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
165 Birks DK, Donson AM, Patel PR, Dunham C, Muscat A, Algar EM, Ashley DM, Kleinschmidt-Demasters BK, Vibhakar R, Handler MH, Foreman NK. High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol 2011;13:1296-307. [PMID: 21946044 DOI: 10.1093/neuonc/nor140] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
166 Savage N, Linn D, McDonough C, Donohoe JM, Franco A, Reuter V, Biddinger PW, Eaton KW, Biegel JA, Sharma S. Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis. Ann Diagn Pathol 2012;16:504-7. [PMID: 21775180 DOI: 10.1016/j.anndiagpath.2011.04.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
167 Pui CH, Gajjar AJ, Kane JR, Qaddoumi IA, Pappo AS. Challenging issues in pediatric oncology. Nat Rev Clin Oncol 2011;8:540-9. [PMID: 21709698 DOI: 10.1038/nrclinonc.2011.95] [Cited by in Crossref: 153] [Cited by in F6Publishing: 158] [Article Influence: 12.8] [Reference Citation Analysis]
168 Pai Panandiker AS, Merchant TE, Beltran C, Wu S, Sharma S, Boop FA, Jenkins JJ, Helton KJ, Wright KD, Broniscer A, Kun LE, Gajjar A. Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. Int J Radiat Oncol Biol Phys 2012;82:1756-63. [PMID: 21601374 DOI: 10.1016/j.ijrobp.2011.02.059] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
169 Schlegel U. Hirntumoren. Klinische Neurologie 2011. [DOI: 10.1007/978-3-642-16920-5_32] [Reference Citation Analysis]
170 Grotzer MA, Shalaby T, Arcaro A. Central Nervous System Atypical Teratoid/Rhabdoid Tumors: Role of Insulin-Like Growth Factor I Receptor. Methods of Cancer Diagnosis, Therapy, and Prognosis 2011. [DOI: 10.1007/978-90-481-8665-5_27] [Reference Citation Analysis]
171 Smith ME, Cimica V, Chinni S, Jana S, Koba W, Yang Z, Fine E, Zagzag D, Montagna C, Kalpana GV. Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1. Proc Natl Acad Sci U S A 2011;108:319-24. [PMID: 21173237 DOI: 10.1073/pnas.0913297108] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
172 Cimica V, Smith ME, Zhang Z, Mathur D, Mani S, Kalpana GV. Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen. BMC Cancer 2010;10:634. [PMID: 21092078 DOI: 10.1186/1471-2407-10-634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
173 Ma HI, Kao CL, Lee YY, Chiou GY, Tai LK, Lu KH, Huang CS, Chen YW, Chiou SH, Cheng IC, Wong TT. Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis. Childs Nerv Syst 2010;26:293-303. [PMID: 19902219 DOI: 10.1007/s00381-009-1016-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
174 Hashizume R, Gupta N, Berger MS, Banerjee A, Prados MD, Ayers-Ringler J, James CD, VandenBerg SR. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing. Neuro Oncol 2010;12:366-76. [PMID: 20308314 DOI: 10.1093/neuonc/nop033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
175 Collins VP. Pathology and Molecular Genetics of Common Brain Tumors. Blue Books of Neurology 2010. [DOI: 10.1016/b978-0-7506-7516-1.00001-3] [Reference Citation Analysis]
176 Heuer GG, Kiefer H, Judkins AR, Belasco J, Biegel JA, Jackson EM, Cohen M, O'Malley BW Jr, Storm PB. Surgical treatment of a clival-C2 atypical teratoid/rhabdoid tumor. J Neurosurg Pediatr 2010;5:75-9. [PMID: 20043739 DOI: 10.3171/2009.8.PEDS08421] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
177 Bui NB. Méningés et cérébraux. Tumeurs malignes rares 2010. [DOI: 10.1007/978-2-287-72070-3_29] [Reference Citation Analysis]
178 Carter MR. Malignant Rhabdoid Tumors of the CNS. Oncology of CNS Tumors 2010. [DOI: 10.1007/978-3-642-02874-8_45] [Reference Citation Analysis]
179 Partap S, Fisher PG. Embryonal Tumors. Pediatric Oncology 2010. [DOI: 10.1007/978-3-540-87979-4_5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Frappaz D, Conter C, Claude L, Szathmaru A, Vasiljevic A. Tumeurs pédiatriques rares. Tumeurs malignes rares 2010. [DOI: 10.1007/978-2-287-72070-3_59] [Reference Citation Analysis]
181 Kalpana GV, Smith ME. Development of Targeted Therapies for Rhabdoid Tumors Based on the Functions of INI1/hSNF5 Tumor Suppressor. Molecularly Targeted Therapy for Childhood Cancer 2010. [DOI: 10.1007/978-0-387-69062-9_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Nicolaides T, Tihan T, Horn B, Biegel J, Prados M, Banerjee A. High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 2010;98:117-23. [PMID: 19936623 DOI: 10.1007/s11060-009-0071-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
183 Marzano E, Lermite E, Nobili C, Teyssedou C, Bachellier P, Arnaud JP, Pessaux P. Malignant rhabdoid tumour of the liver in the young adult: report of first two cases. HPB Surg 2009;2009:628206. [PMID: 19750188 DOI: 10.1155/2009/628206] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
184 Korab Chrzanowska E, Bartoszewska J, Drogosiewicz M, Kwiatkowski S, Skowrońska-gardas A. The importance of radiotherapy in paediatric atypical teratoid rhabdoid tumour of the brain. Reports of Practical Oncology & Radiotherapy 2009;14:53-7. [DOI: 10.1016/s1507-1367(10)60022-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
185 Kieran MW, Chi SN, Samuel D, Lechpammer M, Blackman S, Prabhu SP, Herrington B, Turner C, Marcus KJ, Segal R. Tumors of the Brain and Spinal Cord. Oncology of Infancy and Childhood 2009. [DOI: 10.1016/b978-1-4160-3431-5.00017-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
186 Chastagner P, Klein O, Bernier V, Doz F. Tumeurs cérébrales primitives de l'enfant. EMC - Pédiatrie - Maladies infectieuses 2009;4:1-18. [DOI: 10.1016/s1637-5017(09)72446-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
187 Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009;27:385-9. [PMID: 19064966 DOI: 10.1200/JCO.2008.18.7724] [Cited by in Crossref: 319] [Cited by in F6Publishing: 327] [Article Influence: 21.3] [Reference Citation Analysis]
188 Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R, Milano GM, Garrè ML, Donfrancesco A. A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. J Neurooncol 2009;92:177-83. [PMID: 19048188 DOI: 10.1007/s11060-008-9750-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
189 Warmuth-Metz M, Bison B, Dannemann-Stern E, Kortmann R, Rutkowski S, Pietsch T. CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology. 2008;50:447-452. [PMID: 18345534 DOI: 10.1007/s00234-008-0369-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
190 MacDonald TJ. Aggressive infantile embryonal tumors. J Child Neurol 2008;23:1195-204. [PMID: 18952586 DOI: 10.1177/0883073808321769] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
191 Gottardo NG, Gajjar A. Chemotherapy for malignant brain tumors of childhood. J Child Neurol 2008;23:1149-59. [PMID: 18952581 DOI: 10.1177/0883073808321765] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
192 Pollack IF. Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research. J Child Neurol 2008;23:1179-85. [PMID: 18952584 DOI: 10.1177/0883073808321770] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
193 Ammerlaan AC, Houben MP, Tijssen CC, Wesseling P, Hulsebos TJ. Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation. Childs Nerv Syst 2008;24:855-7. [PMID: 18236049 DOI: 10.1007/s00381-007-0578-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
194 Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC, Lo JF, Chen YJ, Ku HH, Hsu MT, Wong TT. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One 2008;3:e2090. [PMID: 18509505 DOI: 10.1371/journal.pone.0002090] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 6.5] [Reference Citation Analysis]
195 Bouvier C, De Paula AM, Fernandez C, Quilichini B, Scavarda D, Gentet JC, Figarella-Branger D. Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy. Childs Nerv Syst 2008;24:143-7. [PMID: 17968559 DOI: 10.1007/s00381-007-0438-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
196 Ammerlaan AC, Ararou A, Houben MP, Baas F, Tijssen CC, Teepen JL, Wesseling P, Hulsebos TJ. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer 2008;98:474-9. [PMID: 18087273 DOI: 10.1038/sj.bjc.6604156] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
197 Fung K, Trojanowski JQ. Neuromuscular System. The Cancer Handbook 2007. [DOI: 10.1002/9780470025079.chap51.pub2] [Reference Citation Analysis]
198 Grotzer MA, Guerreiro AS, Bourquin JP, Arcaro A. IGF signaling as a therapeutic target in pediatric solid tumors of the central and peripheral nervous system. Expert Rev Endocrinol Metab 2007;2:677-88. [PMID: 30736130 DOI: 10.1586/17446651.2.5.677] [Reference Citation Analysis]
199 Arcaro A, Doepfner KT, Boller D, Guerreiro AS, Shalaby T, Jackson SP, Schoenwaelder SM, Delattre O, Grotzer MA, Fischer B. Novel role for insulin as an autocrine growth factor for malignant brain tumour cells. Biochem J 2007;406:57-66. [PMID: 17506723 DOI: 10.1042/BJ20070309] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
200 Charles AK. Congenital Tumors. Fetal and Neonatal Pathology 2007. [DOI: 10.1007/978-1-84628-743-5_15] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
201 Squire SE, Chan MD, Marcus KJ. Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy. J Neurooncol 2007;81:97-111. [PMID: 16855864 DOI: 10.1007/s11060-006-9196-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 4.2] [Reference Citation Analysis]
202 Reddy AT. Atypical teratoid/rhabdoid tumors of the central nervous system. J Neurooncol 2005;75:309-13. [PMID: 16195799 DOI: 10.1007/s11060-005-6762-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
203 Parmar H, Hawkins C, Bouffet E, Rutka J, Shroff M. Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors. Pediatr Radiol 2006;36:126-32. [PMID: 16341528 DOI: 10.1007/s00247-005-0037-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
204 Arceci R. Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy. Yearbook of Oncology 2006;2006:340-341. [DOI: 10.1016/s1040-1741(08)70235-5] [Reference Citation Analysis]
205 Fuller CE, Perry A. Molecular diagnostics in central nervous system tumors. Adv Anat Pathol 2005;12:180-94. [PMID: 16096380 DOI: 10.1097/01.pap.0000175117.47918.f7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]